NewAmsterdam Pharma Company N.V. Share Price

NewAmsterdam Pharma Company N.V. Share Price

NASDAQ: NAMS | Mid Cap
$20.74
-$0.36 (-1.68%) Last updated on 30 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

NewAmsterdam Pharma Company N.V. Stock Performance

Open
$21.55
Prev. Close
$21.09
Circuit Range
N/A
Day Range
$20.58 - $21.68
Year Range
$19.14 - $42.10
Volume
66,585
Average Traded
$21.00

NewAmsterdam Pharma Company N.V. Share Price Today

As of 30 October 2026, NewAmsterdam Pharma Company N.V.'s share price is $20.74. The stock opened at $21.55, compared to its previous close of $21.09. During today's trading session, NewAmsterdam Pharma Company N.V.'s share price traded between $20.58 and $21.68, with an average price of $21.13. Over the past 52 weeks, the stock has recorded a high of $42.10 and a low of $19.14. In terms of performance, NewAmsterdam Pharma Company N.V.'s share price has declined by 27.36% over the last six months and is down 45.33% on a year-on-year basis.

NewAmsterdam Pharma Company N.V. Share Price Chart

Line chart of the NewAmsterdam Pharma Company N.V. price trend over the selected period. The price fell overall, ranging from 20.58 to 21.72, ending at 20.75.
$20.58$21.68
L
Show Current Price
H

NewAmsterdam Pharma Company N.V. Stock Fundamentals & Key Indicators

Market Cap
$2.46B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.17
Revenue (TTM)
$22.50B
Return On Equity (TTM)
-41.10%
Profit Margin
-905.87%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
10.93%

NewAmsterdam Pharma Company N.V. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.35$0.03$3.04$3.70
Net Profit-$72.01-$74.92-$48.44-$64.14
Net Profit Margin-20574.29%-249733.33%-1593.42%-1733.51%
Income ChangeN/A-4.04%35.34%-32.41%

NewAmsterdam Pharma Company N.V. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$102.69$14.09$45.56$22.50
Net Profit-$22.63-$176.94-$241.60-$203.82
Net Profit Margin-22.04%-1255.78%-530.29%-905.87%
Income ChangeN/A-681.88%-36.54%15.64%

About NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments. The Company has one reportable segment, which comprises the discovery, development, and commercialization of transformative therapies for cardio-metabolic diseases.

NewAmsterdam Pharma Company N.V. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$24.32
$20.76
-14.97%
Sep 2026
$25.42
$24.41
-8.97%
Aug 2026
$27.48
$26.82
-3.40%
Jul 2026
$34.41
$27.77
-18.15%
Jun 2026
$32.71
$33.92
+0.76%
May 2026
$29.11
$33.66
+17.92%
Apr 2026
$32.50
$28.55
-10.78%
Mar 2026
$34.81
$32.00
-9.76%
Feb 2026
$30.77
$35.46
+13.84%
Jan 2026
$35.20
$31.15
-11.20%
Dec 2025
$40.69
$35.08
-15.04%
Nov 2025
$37.73
$41.29
+8.83%

NAMS Share Price FAQs